As of 2025-05-23, the EV/EBITDA ratio of China Tian Yuan Healthcare Group Ltd (557.HK) is -36.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 557.HK's latest enterprise value is 340.70 mil HKD. 557.HK's TTM EBITDA according to its financial statements is -9.27 mil HKD. Dividing these 2 quantities gives us the above 557.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.5x - 4.3x | 3.6x |
| Forward P/E multiples | 2.2x - 5.5x | 3.6x |
| Fair Price | (0.11) - (0.15) | (0.14) |
| Upside | -113.9% - -119.1% | -117.1% |
| Date | EV/EBITDA |
| 2024-10-21 | -27.71 |
| 2024-10-18 | -27.71 |
| 2024-10-17 | -28.58 |
| 2024-10-16 | -28.58 |
| 2024-10-15 | -28.58 |
| 2024-10-14 | -28.58 |
| 2024-10-10 | -28.58 |
| 2024-10-09 | -28.58 |
| 2024-10-08 | -28.15 |
| 2024-10-07 | -34.17 |
| 2024-10-04 | -34.17 |
| 2024-10-03 | -34.17 |
| 2024-10-02 | -34.17 |
| 2024-09-30 | -34.60 |
| 2024-09-27 | -35.46 |
| 2024-09-26 | -36.32 |
| 2024-09-25 | -36.32 |
| 2024-09-24 | -36.32 |
| 2024-09-23 | -36.75 |
| 2024-09-20 | -36.75 |
| 2024-09-19 | -37.18 |
| 2024-09-17 | -37.18 |
| 2024-09-16 | -37.18 |
| 2024-09-13 | -37.18 |
| 2024-09-12 | -37.18 |
| 2024-09-11 | -37.18 |
| 2024-09-10 | -37.18 |
| 2024-09-09 | -37.18 |
| 2024-09-05 | -37.18 |
| 2024-09-04 | -37.18 |
| 2024-09-03 | -38.04 |
| 2024-09-02 | -38.04 |
| 2024-08-30 | -38.04 |
| 2024-08-29 | -38.04 |
| 2024-08-28 | -38.04 |
| 2024-08-27 | -38.04 |
| 2024-08-26 | -38.04 |
| 2024-08-23 | -38.04 |
| 2024-08-22 | -38.04 |
| 2024-08-21 | -38.04 |
| 2024-08-20 | -38.04 |
| 2024-08-19 | -38.04 |
| 2024-08-16 | -38.04 |
| 2024-08-15 | -38.04 |
| 2024-08-14 | -38.04 |
| 2024-08-13 | -38.04 |
| 2024-08-12 | -38.04 |
| 2024-08-09 | -38.47 |
| 2024-08-08 | -38.47 |
| 2024-08-07 | -38.47 |